v3.25.4
Organization and Description of Business Operations - Going Concern, Liquidity and Capital Resources (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Business Combination [Line Items]                    
Accumulated deficit $ 30,702,806           $ 30,702,806   $ 28,665,216  
Loss from operation 701,170     $ 543,147     2,083,601 $ 3,162,876    
Net loss 1,823,351 $ (113,287) $ 327,526 $ 601,372 $ 961,207 $ 1,753,978 2,037,590 $ 3,316,557    
Cash $ 724,502           $ 724,502   56,319  
Liminatus Pharma, LLC                    
Business Combination [Line Items]                    
Accumulated deficit                 28,665,000 $ 25,119,000
Loss from operation                 3,330,000 4,819,000
Net loss                 3,546,000 4,984,000
Cash                 $ 56,000 $ 434,000
Substantial Doubt about Going Concern, within One Year [true false]                 true